NYSE:CVS - CVS Health Stock Price, Price Target & More

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, July 11th. Shareholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a yield of 3.06%. The ex-dividend date is Tuesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 EPS for the quarter, topping the Zacks' consensus estimate of $1.39 by $0.09. The pharmacy operator had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.77 billion. CVS Health had a return on equity of 17.45% and a net margin of 3.59%. The company's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.17 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for CVS Health.

CVS Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

18 brokers have issued 12 month target prices for CVS Health's shares. Their forecasts range from $68.00 to $99.00. On average, they anticipate CVS Health's stock price to reach $86.3125 in the next year. This suggests a possible upside of 32.3% from the stock's current price. View Analyst Ratings for CVS Health.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 5 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

CVS Health saw a increase in short interest in the month of June. As of June 29th, there was short interest totalling 43,844,028 shares, an increase of 0.4% from the June 15th total of 43,662,443 shares. Based on an average daily volume of 9,965,640 shares, the short-interest ratio is currently 4.4 days. Approximately 4.3% of the shares of the company are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Media stories about CVS stock have been trending somewhat positive on Sunday, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CVS Health earned a news impact score of 0.14 on Accern's scale. They also gave media coverage about the pharmacy operator an impact score of 45.61 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.

CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.40%), Swedbank (0.20%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.13%), DnB Asset Management AS (0.12%) and Retirement Systems of Alabama (0.12%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., Atwood & Palmer Inc., DnB Asset Management AS, Swedbank, Hartford Investment Management Co., Gateway Investment Advisers LLC and Welch & Forbes LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Cornerstone Wealth Management LLC, Howard Capital Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Nikko Asset Management Americas Inc., Factory Mutual Insurance Co., Adams Asset Advisors LLC and TNB Financial. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $65.26.

CVS Health has a market capitalization of $66.35 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]